Detalles de la búsqueda
1.
The Predictive Utility of MammaPrint and BluePrint in Identifying Patients with Locally Advanced Breast Cancer Who are Most Likely to Have Nodal Downstaging and a Pathologic Complete Response After Neoadjuvant Chemotherapy.
Ann Surg Oncol
; 30(13): 8353-8361, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37658272
2.
BluePrint breast cancer molecular subtyping recognizes single and dual subtype tumors with implications for therapeutic guidance.
Breast Cancer Res Treat
; 195(3): 263-274, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35984580
3.
Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer.
Ann Surg Oncol
; 2022 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35378634
4.
Henipavirus W Proteins Interact with 14-3-3 To Modulate Host Gene Expression.
J Virol
; 94(14)2020 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32321809
5.
Early Transcriptional Changes within Liver, Adrenal Gland, and Lymphoid Tissues Significantly Contribute to Ebola Virus Pathogenesis in Cynomolgus Macaques.
J Virol
; 94(11)2020 05 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32213610
6.
Prediction of Benefit From Adjuvant Pertuzumab by 80-Gene Signature in the APHINITY (BIG 4-11) Trial.
JCO Precis Oncol
; 8: e2200667, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38237097
7.
CX3CR1-Expressing Myeloid Cells Regulate Host-Helminth Interaction and Lung Inflammation.
Adv Biol (Weinh)
; 6(3): e2101078, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35119218
8.
Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy.
JCO Precis Oncol
; 6: e2200197, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-36108259
9.
Combined 70- and 80-gene signatures identify tumors with genomically luminal biology responsive to neoadjuvant endocrine therapy and are prognostic of 5-year outcome in early-stage breast cancer.
Surg Oncol
; 45: 101885, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36436423
10.
Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene Signature.
JCO Precis Oncol
; 6: e2100463, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35476550
11.
Single Dose of a VSV-Based Vaccine Rapidly Protects Macaques From Marburg Virus Disease.
Front Immunol
; 12: 774026, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34777392
12.
Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection.
mBio
; 10(3)2019 05 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-31138743
13.
Author Correction: Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants.
Sci Rep
; 9(1): 7329, 2019 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31065012
14.
A VP35 Mutant Ebola Virus Lacks Virulence but Can Elicit Protective Immunity to Wild-Type Virus Challenge.
Cell Rep
; 28(12): 3032-3046.e6, 2019 09 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-31533029
15.
Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell Activation.
Front Immunol
; 9: 3071, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30723475
16.
Transcriptomic analysis reveals a previously unknown role for CD8+ T-cells in rVSV-EBOV mediated protection.
Sci Rep
; 7(1): 919, 2017 04 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28428619
17.
Transcriptome Analysis of Circulating Immune Cell Subsets Highlight the Role of Monocytes in Zaire Ebola Virus Makona Pathogenesis.
Front Immunol
; 8: 1372, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29123522
18.
Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants.
Sci Rep
; 7(1): 9730, 2017 08 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-28852031
Resultados
1 -
18
de 18
1
Próxima >
>>